Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gilead Sciences Inc GILD Citi Raises Price Target Ahead of Q1 Biopharma Preview Bolstered by ADC Pipeline Expansion Does ATIF ZBAI stock reflect fair pricing Earnings Report What is the outlook for Orla ORLA stock today Orla posts 95 pct EPS beat vs analyst forecasts AMGN Amgen tops Q4 2025 earnings expectations posts near 10 percent revenue growth shares dip 1 percent iRadimed Corporation IRMD Quarter End iRadimed Corporation reports 103 percent EPS beat The labor dynamics in Neuronetics STIM results Neuronetics posts 81 EPS upside narrower loss Kinder Morgan KMI High Free Cash Flow Midstream Operator Faces Valuation Headwinds Amid Peer Underperformance ATHR Aether shares surge 487 as EPS beat exceeds expectations despite revenue decline and quarterly loss Valero Energy Corporation VLO Ranks Among Top HighGrowth BuyRated Equities for April 29 2026 Trump Holds Off Iran Strike After Gulf State Intervention Cites Ongoing Negotiations Southern SOJC Q1 2026 Results Top Views on Strong Revenue US Bank Analysis How the Job Market Shapes the Broader Economy Mtron Industries MPTI Reports Strong Q4 2025 Revenue NA EPS Beats UAEs Strategic Pipeline Bypassing Strait of Hormuz Nears 50 Completion Key Energy Infrastructure Update Canaan CAN Q1 2026 Results Fall Short EPS 013 Revenue NA Geopolitical Focus Taiwan Arms Sales Emerge as Key Point in TrumpXi Talks Meta Slashes 8000 Jobs in Strategic Pivot Toward AI Expansion IBEX Q1 2026 Earnings EPS Beats Estimates Stock Slips Slightly NFG Q1 2026 Earnings Earnings Miss Estimates Amid Slight Stock Decline ZBIO Q1 2026 Earnings NarrowerthanExpected Loss but Stock Declines NPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise GLNG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency GRI Bio Inc GRI Posts Modest Gains as Stock Holds Above Key Support Prologis Inc PLD Rises 1 as Industrial Real Estate Sector Finds Footing Kymera Therapeutics KYMR Slips Over 2 as Biotech Shares Retreat Support Levels in Focus International General Insurance Holdings IGIC Faces Resistance Slips 266 on Lower Volume